24.03.2011 • News

Chris Viehbacher: Sanofi to Grow Animal Health Through Bolt-On Buys

French drugmaker Sanofi-Aventis plans to expand its Merial animal health business through bolt-on acquisitions, its chief executive said on the sidelines of a conference on Wednesday.

"Bolt-ons are going to be easier" than large acquisitions, Chris Viehbacher said. This was because of competition issues in the increasingly consolidating industry.

Sanofi and Merck on Tuesday dropped plans to combine Merial with Merck's Intervet/Schering Plough (ISP) veterinary business.

Interview

Navigating Uncertainty and Driving Innovation
Meeting Pharma’s Demand for Speed, Reliability, and Flexibility

Navigating Uncertainty and Driving Innovation

Axplora CCO Arul Ramadurai discusses navigating industry uncertainty, building strategic partnerships, and advancing flexible pharmaceutical manufacturing

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

Top-Feature

most read

Photo
News • Chemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.